文献速递肿瘤 PET/CT

18F-FDG-PET/CT肿瘤与肝脏摄取比值(TLR)升高可预测IIA期结直肠癌根治性切除后不良预后

Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-08-15

回顾性分析118例仅接受根治性手术的IIA期结直肠癌患者,评估术前18F-FDG-PET/CT的肿瘤与肝脏摄取比值(TLR)对预后的预测价值。ROC曲线确定TLR最佳截断值为6.2,TLR升高与更差的DFS和OS相关,Cox回归显示TLR>6.2是DFS和OS的独立危险因素。作者认为TLR可能作为识别辅助化疗候选者的影像学指标。

要点

  • TLR预测IIA期结直肠癌复发风险优于原发肿瘤SUVmax,最佳截断值为6.2。
  • TLR≤6.2组5年DFS为96.9%,TLR>6.2组为60.6%。
  • TLR>6.2是DFS和OS的独立危险因素。

核心结论

  • TLR升高预测IIA期结直肠癌患者更差的DFS和OS,可能作为识别新辅助或辅助化疗候选者的潜在影像学指标。
  • TLR升高的IIA期结直肠癌患者应仔细监测以便早期发现可能的复发。

研究设计与样本

  • 回顾性分析2010年4月至2013年12月在中山大学附属第六医院接受18F-FDG-PET/CT扫描的504例不同TNM分期(I-IV)连续结直肠癌患者中的118例IIA期患者,均接受术前18F-FDG-PET/CT且仅行根治性手术。

主要发现

  • ROC曲线分析显示TLR在预测IIA期结直肠癌复发风险方面优于原发肿瘤SUVmax,最佳TLR截断值为6.2。
  • 单因素分析显示TLR升高、肿瘤大小和淋巴血管/神经侵犯与DFS相关(P=0.001、P=0.002和P=0.001)及与OS相关(P=0.001、P=0.003和P<0.001)。
  • TLR≤6.2组1年、3年和5年DFS率分别为98.4%、96.9%和96.9%,TLR>6.2组分别为77.8%、60.6%和60.6%。
  • TLR≤6.2组1年、3年和5年OS率分别为100.0%、100.0%和98.3%,TLR>6.2组分别为98.1%、83.3%和74.3%。
  • Cox回归分析显示TLR>6.2(HR范围3.109-57.463,P<0.001)和肿瘤大小>4.4 cm(HR范围1.636-19.155,P=0.006)是DFS的独立危险因素;TLR>6.2(HR范围1.398-84.945,P=0.023)和淋巴血管/神经侵犯阳性(HR范围1.278-12.777,P=0.017)是OS的独立危险因素。

关键数值与推荐

  • TLR最佳截断值为6.2。
  • TLR>6.2是DFS的独立危险因素(HR范围3.109-57.463,P<0.001)。
  • TLR>6.2是OS的独立危险因素(HR范围1.398-84.945,P=0.023)。

临床怎么用

  • 作者认为TLR升高可能作为识别IIA期结直肠癌新辅助或辅助化疗候选者的潜在影像学指标。
  • 作者建议对TLR升高的IIA期结直肠癌患者仔细监测以便早期发现可能的复发。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prognostic value of the tumor-to-liver uptake ratio (TLR) from 18-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in the early stage of colorectal cancer (CRC) is unclear. Notably, some stage IIA CRC patients experience early recurrence even after curative resection and might benefit from neoadjuvant or adjuvant chemotherapy. This study aims to evaluate whether elevated TLR from 18F-FDG-PET/CT can predict poor prognosis in stage IIA CRC patients undergoing curative resection. METHODS: From April 2010 to December 2013, 504 consecutive CRC patients with different TNM stages (I-IV) underwent 18F-FDG-PET/CT scans at the 6th Affiliated Hospital of Sun Yat-Sen University. Among the patients, 118 with stage IIA CRC who accepted preoperative 18F-FDG-PET/CT scanning and were treated with curative surgery alone were reviewed retrospectively. The maximum standardized uptake value (SUVmax) in the primary tumor, TLR, and demographic, clinical, histopathological, and laboratory data were analyzed. Receiver operating characteristic (ROC) curve, univariate and multivariate analyses were performed to identify prognostic factors associated with patient disease-free survival (DFS) and overall survival (OS). RESULTS: ROC curve analysis demonstrated that TLR was superior to primary tumor SUVmax in predicting the risk of recurrence in stage IIA CRC. The optimal TLR cutoff was 6.2. Univariate analysis indicated that elevated TLR, tumor size, and lymphovascular/neural invasion correlated with DFS (P = 0.001, P = 0.002, and P = 0.001, respectively) and OS (P = 0.001, P = 0.003, and P < 0.001, respectively). The 1-, 3-, and 5-year DFS rates were 98.4%, 96.9%, and 96.9% for stage IIA CRC patients with lower TLR (≤6.2) versus 77.8%, 60.6%, and 60.6% for those with elevated TLR (>6.2), respectively. The 1-, 3-, and 5-year OS rates were 100.0%, 100.0%, and 98.3% for the patients with lower TLR versus 98.1%, 83.3%, and 74.3% for those with elevated TLR. Cox regression analysis showed that elevated TLR [>6.2; hazard ratio (HR): 3.109-57.463; P < 0.001] and tumor size (>4.4 cm; HR: 1.636-19.155; P = 0.006) were independent risk factors for DFS. Meanwhile, elevated TLR (>6.2; HR: 1.398-84.945; P = 0.023) and lymphovascular/neural invasion (positive; HR: 1.278-12.777; P = 0.017) were independent risk factors for OS. CONCLUSION: Elevated TLR predicted worse DFS and OS for stage IIA CRC patients and might serve as a potential radiological index to identify candidates for neoadjuvant or adjuvant chemotherapy. Stage IIA CRC patients with elevated TLR should be monitored carefully for early detection of possible recurrence.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Huang J, Huang L, Zhou J, et al. Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection. Eur J Nucl Med Mol Imaging. 2017. PMID: 28812134. doi:10.1007/s00259-017-3779-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。